Author:
Wiltschke Christoph,Köstler Wolfgang
Reference48 articles.
1. Ainslie J, Burdon JG, Henderson MM, Ilbery PL, Matthews JP (1983) The use of levamisole as an adjunct to chemotherapy and radiotherapy in the treatment of small cell carcinoma of the lung. Med J Aust 2(6): 285–287.
2. Ardizzoni A, Salvati F, Rosso R, Bruzzi P, Rubagotti A, Pennucci MC, Mariani GL, De Marinis F, Pallotta G, Antilli A, et al. (1993) Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer. Multiccntric Randomized FONICAP Trial Report. The Italian Lung Cancer Task Force. Cancer 72(10): 2929–2935.
3. Arnold A, Ayoub J, Douglas L, Hoogendoorn P, Skingley L, Gelmon K, Hirsh V, Eisenhauer E (1994) Phase II trial of 13-cis-retinoic acid plus interferon alpha in nonsmall-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Natl Cancer Inst 86(4): 306–309.
4. Behr TM, Sharkey RM, Juweid ME, Dunn RM, Vagg RC, Ying Z, Zhang CH, Swayne LC, Vardi Y, Siegel JA, et al. (1997) Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG. J Nucl Med 38(6): 858–870.
5. Bukowski RM, Murthy S, McLain D, Finke J, Andresen S, Tubbs R, Bauer L, Gibson V, Budd GT, Thomassen MJ (1993) Phase I trial of recombinant granulocyte-macrophage colony-stimulating factor in patients with lung cancer: Clinical and immunologic effects. J Immunother 13(4): 267–274.